filmov
tv
Gene Therapy and Hemophilia A
Показать описание
Adrian Woolfson, MD, PhD, of Sangamo Therapeutics talks about the physical and psychological advantages of using gene therapy to treat hemophilia A.
Hemophilia A is a genetic blood disorder caused by a missing or defective factor VIII. Symptoms are dependent on the level factor VIII present but in more severe cases, excessive bleeding can lead to severe pain, especially at joints.
Currently, most person with severe hemophilia A take a recombinant factor VIII product to control bleeding. Unlike those treatments that require a lifetime of regular infusions, the gene therapy being developed by Sangamo Therapeutics would require just one injection that would ‘cure’ the person of the disease.
Hemophilia A is a genetic blood disorder caused by a missing or defective factor VIII. Symptoms are dependent on the level factor VIII present but in more severe cases, excessive bleeding can lead to severe pain, especially at joints.
Currently, most person with severe hemophilia A take a recombinant factor VIII product to control bleeding. Unlike those treatments that require a lifetime of regular infusions, the gene therapy being developed by Sangamo Therapeutics would require just one injection that would ‘cure’ the person of the disease.
Gene Therapy: An End to Hemophilia
Hemophilia and Gene Therapy
AAV gene therapies for hemophilia A and B
Gene Therapy for Hemophilia: Progress and Conundrums
Improved quality of life in patients with hemophilia A following gene therapy
Gene Therapy: Hemophilia
The challenges of implementing gene therapies for hemophilia in clinical practice
Spark's hemophilia gene therapy reduced bleeds by 97% trial
Gene Therapy for Treatment of Hemophilia: An Introduction to AAV Vector Gene Transfer
Gene Therapy for Hemophilia
Gene Therapy and Hemophilia A
Big pharma companies vie for hemophilia gene therapy breakthrough
Improving outcomes for hemophilia patients through the implementation of gene therapies
Gene Therapy for Hemophilia A
Gene therapy as a future treatment for hemophilia
Gene Therapy in Hemophilia
Current hurdles in AAV-based gene therapy for hemophilia
The future generations of gene therapy for hemophilia
Highlights from ISTH: gene therapy in hemophilia A & undiagnosed bleeding disorders in pediatric...
The importance of liver health in patients participating in hemophilia gene therapy clinical trials
FDA approves gene therapy for adults with Hemophilia B
Gene Therapy for Treatment of Hemophilia: AAV Vector Gene Therapy Application to Hemophilia
Immune response monitoring in patients with hemophilia treated with gene therapy
A detailed overview of the current and emerging gene therapies for hemophilia A & B
Комментарии